
QURE
USDuniQure N.V. Ordinary Shares
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$30.810
High
$32.490
Low
$28.500
Volume
8.90M
Company Fundamentals
Market Cap
1.9B
Industry
Biotechnology
Country
Netherlands
Trading Stats
Avg Volume
3.75M
Exchange
NMS
Currency
USD
52-Week Range
Related News
uniQure N.V. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (QURE)
NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against uniQure N.V. ("uniQure" or the "Company") (NASDAQ:QURE). The investigation concerns whether the
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy
William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval timeline.
Goldman Sachs Maintains Neutral on uniQure, Lowers Price Target to $38
Goldman Sachs analyst Salveen Richter maintains uniQure with a Neutral and lowers the price target from $56 to $38.
RBC Capital Maintains Outperform on uniQure, Lowers Price Target to $45
RBC Capital analyst Luca Issi maintains uniQure with a Outperform and lowers the price target from $65 to $45.
William Blair Downgrades uniQure to Market Perform
William Blair analyst Sami Corwin downgrades uniQure from Outperform to Market Perform.
HC Wainwright & Co. Maintains Buy on uniQure, Lowers Price Target to $70
HC Wainwright & Co. analyst Patrick R. Trucchio maintains uniQure with a Buy and lowers the price target from $110 to $70.
Chardan Capital Maintains Buy on uniQure, Lowers Price Target to $53
Chardan Capital analyst Daniil Gataulin maintains uniQure with a Buy and lowers the price target from $76 to $53.
Related Stocks
CRDL
Cardiol Therapeutics Inc. Common Shares
ST
Sensata Technologies Holding plc Ordinary Shares
ABCL
AbCellera Biologics Inc. Common Shares
GTHX
G1 Therapeutics Inc.
MOLN
Molecular Partners AG American Depositary Shares
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.